A cytotoxic drug against reperfusion injury?
Rüdiger
H A
HA
Clavien
P A
PA
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004317:Doxorubicin / Q000627:therapeutic use*; D004790:Enzyme Induction / Q000502:physiology; D006419:Heme Oxygenase (Decyclizing) / Q000378:metabolism*; D051547:Heme Oxygenase-1; D006801:Humans; D008102:Liver Circulation / Q000187:drug effects*; D008565:Membrane Proteins; D015427:Reperfusion Injury / Q000517:prevention & control*
D000970:Antineoplastic Agents; D008565:Membrane Proteins; D004317:Doxorubicin; C496541:HMOX1 protein, human; D006419:Heme Oxygenase (Decyclizing); D051547:Heme Oxygenase-1